Abstract: A pixel herein includes a color panel, a light emitting diode (LED) panel, and an adhesive layer disposed between the color panel and the LED panel. The color panel includes a transparent layer, a plurality of sub-pixel isolation structures, and a plurality of black matrix structures disposed between the plurality of sub-pixel isolation structures and the transparent layer. The sub-pixel isolation structures define a plurality color conversion wells of plurality of sub-pixels. A color conversion material is disposed in the color conversion well. The plurality of black matrix structures define a plurality of color resist wells of the plurality of sub-pixels. A color resist is disposed in the color resist wells. The LED panel includes a plurality of micro-LEDs disposed on a backplane. The plurality of micro-LEDs correspond to a sub-pixel.

Abstract: The present invention provides the use of one or more active ingredients that can reduce the adverse effects of particulate matter (PM) on the skin, the active ingredients include polyphenolic substances. The active ingredient disclosed herein can significantly reduce the adverse effects of skin caused by PMs, and can be applied in many different aspects, such as skin care products with anti-pollution and anti-haze effect.

Abstract: Disclosed is a skin care composition comprising: (1) from about 0.001% to about 10% of a flavonoid compound; (2) from about 0.01% to about 15% of a vitamin B3 compound; and (3) a dermatologically acceptable oil-in-water carrier comprising at least about 2% by weight of the entire composition of an oil component.

Abstract: Disclosed is a skin care device comprising: (1) a dermatologically acceptable preformed substrate and (2) a flavonoid compound, wherein the device comprises a liquid medium for delivering the flavonoid compound.

Abstract: Disclosed is a skin care composition comprising: (1) from about 0.001% to about 10% of a flavonoid compound; (2) from about 0.01% to about 15% of a vitamin B3 compound; and (3) a dermatologically acceptable oil continuous phase carrier.

Abstract: Disclosed is a composition comprising: (1) from about 0.001% to about 10% of a flavonoid compound; (2) from about 0.01% to about 15% of a vitamin B3 compound; and (3) a dermatologically acceptable single aqueous phase carrier.